Related Experiment Video
Updated: Aug 11, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study
S Thongprasert1, S Maoleekoonpairoj, S Laohavinij
1Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Purpose:
To evaluate the efficacy and toxicity of UFT plus oral leucovorin in advanced colorectal cancer.
Material And Method:
Twenty cases of advanced colorectal cancer were entered into the study. All patients must have histologic proof and have measurable disease. Prior to the treatment all patients should have normal baseline hematology and normal liver and renal function, ECOG Performance status < or = 2 and age 18-75 years. Chemotherapeutic drugs consisted of UFT 350 mg/m2/day divided into 3 doses (8 hours apart) plus oral leucovorin 15 mg every 8 hours. Duration of treatment was 21 days per each cycle. Treatment was recycled every 28 days.
Results:
Four cases (22.2%) had partial responses and six cases (33.3%) had stable disease. Duration of response was 4(+)-7+ months. Toxicity was darkened skin, mild diarrhea and mild alopecia.
Conclusion:
UFT plus oral leucovorin was one of the active regimens in the treatment of advanced colorectal cancer.
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase